HuGE Literature Finder
Records
1
-
30
| Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis. Frontiers in cardiovascular medicine 2021 8 651269. Yang Xinyu, Li Guoping, Guan Manke, Bapat Aneesh, Dai Qianqian, Zhong Changming, Yang Tao, Luo Changyong, An Na, Liu Wenjing, Yang Fan, Pan Haie, Wang Pengqian, Gao Yonghong, Gong Ye, Das Saumya, Shang Hongcai, Xing Yanw |
| Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation. Basic & clinical pharmacology & toxicology 2020 Sep . Nakagawa Junichi, Kinjo Takahiko, Iizuka Mei, Ueno Kayo, Tomita Hirofumi, Niioka Takeno |
| Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific reports 2020 Aug 10 (1): 13486. Atasilp Chalirmporn, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sukasem Chonlaph |
| ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone. Progress in neuro-psychopharmacology & biological psychiatry 2020 Jul 110042. Ganoci Lana, Trkulja Vladimir, Živkovic Maja, Božina Tamara, Šagud Marina, Lovric Mila, Božina Na |
| Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients' Population. International journal of environmental research and public health 2020 May 17 (10): . Bojanic Kristina, Kuna Lucija, Bilic Curcic Ines, Wagner Jasenka, Smolic Robert, Kralik Kristina, Kizivat Tomislav, Ivanac Gordana, Vcev Aleksandar, Wu George Y, Smolic Marti |
| CYP4F2 and CYP3A5 gene polymorphisms and lung cancer in Chinese Han population. Clinical and experimental medicine 2020 Apr . He Ruiqing, Li Meng, Li Anqi, Dang Wenhui, Yang Tian, Li Jing, Zhang Ning, Jin Tianbo, Chen Mingw |
| Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients. The pharmacogenomics journal 2020 Feb . Bonnet Stéphanie, Falkowski Sabrina, Deppenweiler Marine, Monchaud Caroline, Arnion Hélène, Picard Nicolas, Woillard Jean-Baptis |
| The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer. Cancer chemotherapy and pharmacology 2020 Jan . Belderbos Bodine P S, de With Mirjam, Singh Rajbir K, Agema Bram C, El Bouazzaoui Samira, Oomen-de Hoop Esther, de Wit Ronald, van Schaik Ron H N, Mathijssen Ron H J, Bins Sand |
| Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Patients. Frontiers in pharmacology 2020 11 664. Liao Dehua, Liu Zhigang, Zhang Yongchang, Liu Ni, Yao Dunwu, Cao Lizhi, Chen Yun, Fu Yilan, Yang Nong, Xiang Daxio |
| Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer. European review for medical and pharmacological sciences 2019 Nov 23 (21): 9393-9410. Pu J, Wang N, Huang Z-K, He X-Y, Yuan H |
| Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care. Journal of thrombosis and thrombolysis 2019 Sep . Gulilat Markus, Keller Denise, Linton Bradley, Pananos A Demetri, Lizotte Daniel, Dresser George K, Alfonsi Jeffrey, Tirona Rommel G, Kim Richard B, Schwarz Ute |
| Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers. Archives of gynecology and obstetrics 2019 May . de Castro Clarissa Lourenço, da Costa Junior Luiz Carlos, Lourenço Letícia Vieira, Seba Karine Souza, da Silva Taiana Sousa Lopes, Vianna-Jorge Rosa |
| Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Scientific reports 2019 Apr 9 (1): 5404. Ozeki Tomoko, Nagahama Mitsuji, Fujita Kazuma, Suzuki Akifumi, Sugino Kiminori, Ito Koichi, Miura Masato |
| Genetic Variation in Steroid and Xenobiotic Metabolizing Pathways and Enterolactone Excretion Before and After Flaxseed Intervention in African American and European American Women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Feb 28 (2): 265-274. Chang Huiru, Yao Song, Tritchler David, Hullar Meredith A, Lampe Johanna W, Thompson Lilian U, McCann Susan |
| Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients. Pharmacogenomics 2018 Sep . Sim Sarah, Bergh Jonas, Hellström Mats, Hatschek Thomas, Xie Hanji |
| Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Pharmacogenetics and genomics 2018 Aug . Zgheib Nathalie K, Ghanem Khaled M, Tamim Hani, Aridi Carole, Shahine Randa, Tarek Nidale, Saab Raya, Abboud Miguel R, El-Solh Hassan, Muwakkit Samar |
| Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients. European journal of clinical pharmacology 2018 Jul . Tanaka Hironari, Naito Takafumi, Sato Hikaru, Hiraide Takanori, Yamada Yasuhide, Kawakami Junic |
| Association of CYP3A5*3 polymorphisms and prostate cancer risk: A meta-analysis. Journal of cancer research and therapeutics 2018 Jun 14 (Supplement): S463-S467. Liang Ying, Han Wen, Yan Hongwei, Mao Qi |
| Detection of Cytochrome P450 Polymorphisms in Breast
Cancer Patients May Impact on Tamoxifen Therapy Asian Pacific journal of cancer prevention : APJCP 2018 Feb 19 (2): 343-350. Thota Kanakaiah, Prasad K, Basaveswara Rao Mandava |
| CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer. Pediatric blood & cancer 2018 03 65 (3): . Skiles Jodi L, Chiang ChienWei, Li Claire H, Martin Steve, Smith Ellen L, Olbara Gilbert, Jones David R, Vik Terry A, Mostert Saskia, Abbink Floor, Kaspers Gertjan J, Li Lang, Njuguna Festus, Sajdyk Tammy J, Renbarger Jamie |
| Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles. Anticancer research 2018 03 38 (3): 1455-1459. Fiszer-Maliszewska ?ucja, ?aczma?ski ?ukasz, Doli?ska Aneta, Jagas Maria, Ko?odziejska Ewelina, Jankowska Magdalena, Ku?nierczyk Pio |
| Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters. Biological & pharmaceutical bulletin 2018 41 (1): 47-56. Endo-Tsukude Chihiro, Sasaki Ji-Ichiro, Saeki Sho, Iwamoto Norihiro, Inaba Megumi, Ushijima Sunao, Kishi Hiroto, Fujii Shinji, Semba Hiroshi, Kashiwabara Kosuke, Tsubata Yukari, Hayashi Mitsuhiro, Kai Yuki, Saito Hideyuki, Isobe Takeshi, Kohrogi Hirotsugu, Hamada Akino |
| Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer chemotherapy and pharmacology 2017 Jul . Mbatchi Litaty C, Gassiot Matthieu, Pourquier Philippe, Goberna Alejando, Mahammedi Hakim, Mourey Loic, Joly Florence, Lumbroso Serge, Evrard Alexandre, Houede Nadi |
| The influence of CYP3A5*3 and BCRPC421A genetic polymorphisms on the pharmacokinetics of felodipine in healthy Chinese volunteers. Journal of clinical pharmacy and therapeutics 2017 Feb . Xiang Q, Li C, Zhao X, Cui Y |
| Influence of cytochrome P450 genotype on the plasma disposition of prochlorperazine metabolites and their relationships with clinical responses in cancer patients. Annals of clinical biochemistry 2017 Jan 4563217731432. Tashiro Masaki, Naito Takafumi, Kagawa Yoshiyuki, Kawakami Junic |
| Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients. Breast cancer (Dove Medical Press) 2017 9 249-256. Charoenchokthavee Wanaporn, Areepium Nutthada, Panomvana Duangchit, Sriuranpong Viro |
| Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L. Frontiers in pharmacology 2017 8 712. Labriet Adrien, De Mattia Elena, Cecchin Erika, Lévesque Éric, Jonker Derek, Couture Félix, Buonadonna Angela, D'Andrea Mario, Villeneuve Lyne, Toffoli Giuseppe, Guillemette Chant |
| Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes. Anticancer research 2017 05 37 (5): 2633-2639. Angelini Silvia, Botticelli Andrea, Onesti Concetta Elisa, Giusti Raffaele, Sini Valentina, Durante Valeria, Strigari Lidia, Gentile Giovanna, Cerbelli Bruna, Pellegrini Patrizia, Sgroi Valentina, Occhipinti Mario, DI Pietro Francesca Romana, Rossi Alessandro, Simmaco Maurizio, Mazzuca Federica, Marchetti Pao |
| Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies. The pharmacogenomics journal 2016 Dec . Meulendijks D, Rozeman E A, Cats A, Sikorska K, Joerger M, Deenen M J, Beijnen J H, Schellens J H |
| Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study. Medicine 2016 Nov 95 (44): e5151. Tsuji Daiki, Ikeda Midori, Yamamoto Keisuke, Nakamori Harumi, Kim Yong-Il, Kawasaki Yohei, Otake Aki, Yokoi Mari, Inoue Kazuyuki, Hirai Keita, Nakamichi Hidenori, Tokou Umi, Shiokawa Mitsuru, Itoh Kunihi |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 12, 2022
- Content source: